Ginkgo Bioworks
BOSTON, Massachusetts, United States · Biotechnology, Manufacturing, Other
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detec
Key facts
- Headquarters
- BOSTON, Massachusetts, United States
- Employees
- 840
- Industries
- Biotechnology, Manufacturing, Other
- Status
- Public (DNA)
- Website
- ginkgobioworks.com
- Company page
Recent activity at Ginkgo Bioworks
- : Ginkgo Bioworks Partners with Eli Lilly for AI Drug Discovery to Boost Business Opportunities.
- : Ginkgo Bioworks launched its Ginkgo Datapoints service to provide discovery data generation services for AI-driven drug discovery.
- : Ginkgo Bioworks partners with Acies Bio to enhance fungal protein production through engineered Aspergillus niger strains.
- : SEC 8-K (7.01):
- : Ginkgo Bioworks launches ADME-One™, a high-throughput ADME platform for drug discovery co-developed with Tangible Scientific and Inductive Bio.
- : Ginkgo Bioworks Holdings Acquires Tower Biosecurity
- : SEC 8-K (2.01):
- : SEC 8-K (2.01): On April 3, 2026, Ginkgo Bioworks, Inc., a subsidiary of Ginkgo Bioworks Holdings, Inc., completed the acquisition related to a Stock Purchase Agreement with Tower Biosecurity, Inc. (also known as Perimeter Systems, Inc.). The agreement, originally dated February 26, 2026, resulted in the sale of all issued and outstanding shares of a specific business unit. This strategic move is intended to enhance Ginkgo's capabilities in the biosecurity domain, aligning with their growth objectives. The financial terms of the transaction were not disclosed, but it represents a significant step for Ginkgo in expanding its market presence.
- : Ginkgo Bioworks Acquires Ginkgo Biosecurity
- : SEC 8-K (1.01): On February 26, 2026, Ginkgo Bioworks, Inc., a subsidiary of Ginkgo Bioworks Holdings, Inc., entered into a Stock Purchase Agreement with Tower Biosecurity, Inc. and Ginkgo Biosecurity, LLC. Under this agreement, Ginkgo will sell all issued equity interests of its Biosecurity segment to Tower Biosecurity in exchange for approximately 20% of Tower Biosecurity's common stock. The transaction is expected to close in the first half of 2026, subject to customary conditions. This strategic move allows Ginkgo to focus on its core operations while still maintaining a significant equity stake in the Purchaser.
Ginkgo Bioworks funding history
| Date | Round | Amount |
|---|---|---|
| May 2020 | Venture | $70.0M |
| Sep 2015 | Venture | $51.6M |
| Jul 2015 | Venture | $50.0M |
Leadership
- Reshma Shetty, Founder
- Jason Kelly, Cofounder
- Philipp Heuermann, Director - Business Development, Ginkgo Datapoints
- Max Breet, Senior Director - EMEA Business Development
- Steven Coen, Chief Financial Officer
- Barry Canton, Chief Technology Officer
Verified email and direct lines for Ginkgo Bioworks’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Ginkgo Bioworks files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Ginkgo Bioworks in the news
- Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation - Investing News Network (Apr 30, 2026)
- Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab - PR Newswire (May 07, 2026)
- Ginkgo to Acquire Zymergen - BioSpace (Jul 25, 2022)
- Ginkgo Bioworks Reports Third Quarter 2025 Financial Results - PR Newswire (Nov 06, 2025)
- Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business - PR Newswire (Feb 26, 2026)
- Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment - PR Newswire (Dec 17, 2025)
- Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results - PR Newswire (Feb 25, 2025)
- OneOne Biosciences Partners with Ginkgo Bioworks to Advance its Platform and Nitrogen Fixation Microbial Product - PR Newswire (Dec 20, 2023)
Companies similar to Ginkgo Bioworks
- Antares Vision SpA · Biotechnology, Manufacturing, Other, Software
- Redwire Corporation · Manufacturing, Other, Science And Engineering, Software
- Agility Robotics · Manufacturing, Other, Science And Engineering, Software
- The Hain Celestial Group · Biotechnology, Manufacturing, Science And Engineering, Sustainability
- Conversica · Other, Science And Engineering, Software, Sustainability
About Ginkgo Bioworks: questions and answers
What does Ginkgo Bioworks do?
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detec
Where is Ginkgo Bioworks headquartered?
Ginkgo Bioworks is headquartered in BOSTON, Massachusetts, United States.
How many employees does Ginkgo Bioworks have?
Ginkgo Bioworks has about 840 employees.
Has Ginkgo Bioworks raised funding?
Yes. Fundz has recorded 3 funding events for Ginkgo Bioworks. The most recent, $70.0M, was in May 2020.
Who leads Ginkgo Bioworks?
Reshma Shetty is a Founder at Ginkgo Bioworks.
What is the latest news on Ginkgo Bioworks?
On Oct 05, 2026, Ginkgo Bioworks Partners with Eli Lilly for AI Drug Discovery to Boost Business Opportunities.
Is Ginkgo Bioworks a public company?
Yes. Ginkgo Bioworks is publicly traded under the ticker DNA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy